<HashMap><database>iProX</database><scores/><additional><omics_type>Proteomics</omics_type><submitter>Yunzi Mao</submitter><species>Homo Sapiens</species><full_dataset_link>http://www.iprox.org/page/project.html?id=IPX0018359000</full_dataset_link><submitter_email>maoyz@fudan.edu.cn</submitter_email><submitter_affiliation>Fudan University</submitter_affiliation><sample_protocol></sample_protocol><repository>iProX</repository><data_protocol></data_protocol></additional><is_claimable>false</is_claimable><name>ATRIP Lactylation Induces Cell Cycle Arrest Escape and Chemoresistance</name><description>Elevated lactate levels were associated with chemoresistance across multiple cancer types. Mechanistically, lactylation of ATRIP at lysine 270 (Lac-K270) enhanced ATR-ATRIP interaction, resulting in aberrant ATR activation and subsequent checkpoint kinase 1 (CHK1) degradation via the ubiquitin-proteasome pathway. This rewired the ATR-CHK1 DDR pathway, enabling cancer cells to bypass chemotherapy-induced cell cycle arrest and survive genotoxic stress. Lac-K270 was catalyzed by alanyl-tRNA synthetase 1 (AARS1) and reversed by the deacetylase sirtuin 1 (SIRT1). Pharmacological inhibition of Lac-K270 with alaninol effectively re-sensitized chemoresistant tumors to genotoxic drugs in both in vitro and animal models.</description><dates><publication>Tue Jul 21 00:00:00 GMT+01:00 2026</publication></dates><accession>PXD081427</accession><cross_references><TAXONOMY>9606</TAXONOMY></cross_references></HashMap>